Epidemiology of prostate cancer in the Asia-Pacific region.
about
Comprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countriesPsycho-oncology assessment in Chinese populations: a systematic review of quality of life and psychosocial measures.Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate CarcinomaAssociation between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancerCorrelation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice.Relationships between cancer pattern, country income and geographical region in AsiaDetection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate CancerExploring Geographic Variability in Cancer Prevalence in Eastern Morocco: A Retrospective Study over Eight YearsEpidemiology of prostate cancer in South KoreaIncreased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms-A whole of population study.Serum adiponectin concentration in 2,939 Japanese men undergoing screening for prostate cancer.Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer.The incidence and mortality of prostate cancer and its relationship with development in Asia.Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition.I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signalingProstate Cancer Mortality-To-Incidence Ratios Are Associated with Cancer Care Disparities in 35 Countries.Combination of clinical characteristics and transrectal ultrasound-guided biopsy to predict lobes without significant cancer: application in patient selection for hemiablative focal therapy.Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases.Ethyl Acetate Extracts of Semen Impatientis Inhibit Proliferation and Induce Apoptosis of Human Prostate Cancer Cell Lines through AKT/ERK Pathways.Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer.Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment.Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer.Evaluation of PSF1 as a prognostic biomarker for prostate cancer.Gonorrhea infection increases the risk of prostate cancer in Asian population: a nationwide population-based cohort study.Clinical comparison of the efficacy of three different bowel preparation methods on the infectious complications following transrectal ultrasonography-guided prostate biopsy in nursing practice.Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009.Association between single nucleotide polymorphism in miR-499, miR-196a2, miR-146a and miR-149 and prostate cancer risk in a sample of Iranian population.Symmetry based prostate cancer detection.Pudendal nerve injury in men with fecal incontinence after radiotherapy for prostate cancer.Evaluation of a 3-base pair indel polymorphism within pre-microRNA-3131 in patients with prostate cancer using mismatch polymerase chain reaction-restriction fragment length polymorphism.Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups.Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan.Genetic Variations in Inflammatory Response Genes and Their Association with the Risk of Prostate Cancer.Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors.Influence of the contrast agents on treatment planning dose calculations of prostate and rectal cancers.Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cellsSuccessful resection of a solitary metastatic liver tumor from prostate cancer 15 years after radical prostatectomy: a case report.Association between LAPTM4B gene polymorphism and prostate cancer susceptibility in an Iranian population.Multimodal therapy for locally advanced prostate cancer: the roles of radiotherapy, androgen deprivation therapy, and their combination.Scientific publications in andrology journals from Chinese authors in various parts of East Asia: a 10-year survey of the literature.
P2860
Q26996461-F90F200E-1BAE-43C1-8B9E-732B414DC417Q30252103-FE898BE4-FB5A-4EE3-BD3B-B9F7B4CAED44Q33584215-286E006C-F994-4E43-A059-522C131ABE65Q33597618-7D3D31D9-C21E-4122-926D-5D586DAD412EQ34294898-59516E31-2777-42B0-8442-9990C8795DE0Q35763350-98B6B47E-1A67-47F5-94AF-5B13A74A2CC5Q35782031-810DAE1D-2646-427A-9CC3-1B36F5A3A3A0Q35964558-0512D9DF-DF3A-43B6-BADC-970DB913F7BCQ36106212-F7E0A900-B17B-411D-BFC4-CCD0E6ED63A3Q36106227-F5193639-AC62-49DA-9A4B-CECC3246D74DQ36106260-9D03402D-29BF-4A1E-A0F6-C416BE87F48FQ36250649-5266088F-63EA-427B-B518-7229DF7D8E70Q36387818-154A44B6-CB62-4A50-BF9D-30DCF71CC9A0Q36592493-193FB907-285F-4E38-A7CB-1498A9BE48E1Q36746278-0D1DF455-DE81-4D28-AFC9-50E7E63217D8Q37554581-BF5B52C4-BBC7-483F-8464-83E92D07074FQ37676133-CD46EE0C-C9D4-4019-942E-3858F3B7F888Q38603373-2A4FD66F-325D-47F6-B797-9C54823ECEE4Q38708570-113D4167-E075-444E-B68A-F60FEFF84DBFQ38721751-6E0EF7B8-BE40-4610-8C7D-3E8BCDD49917Q38790667-EB833CC8-4076-40DE-9C55-E64BA7A98163Q38898477-C53CD32D-2B1E-4DD0-A579-4A2FAC040406Q38939897-6061FF1D-EB0C-4D36-9CEF-F91939C72796Q39577318-A3417040-AD0C-4354-957A-BF28556F6472Q40061414-939C36D4-3252-4D9E-AA6E-B6F7A49B451BQ40297420-86D63308-2F92-4088-8B7C-C3BC10572252Q41004837-790BF3E1-3100-4331-9C46-3132D6797811Q41032331-87C93C21-CAC3-4CE3-B4AE-4B526FEF84B9Q41313424-5B4BF3D5-797A-4707-B711-6758A15568C5Q41542584-AB7193CB-E78F-432C-92F3-CB20D6BD6A85Q41564601-7B8FE1A7-703D-47BB-B3FB-8C4971D35DE7Q41861697-2C6712EE-B2CA-4FC1-B79F-E19EFBC86E6EQ41888259-C4D83B2C-96BE-414D-AB0A-481D5830D013Q41996680-E354EBC5-EF5A-4A7D-BB97-B3E8F61BCD7EQ42144145-4297CBC4-7680-43A2-88F4-8B338208534CQ42265978-4072FED0-B0C8-4C3D-9B33-DE121D586348Q42327937-F1241A42-28BC-4D3E-92DB-B0869B637DE4Q42351255-F011CADB-49CB-403D-B5D5-5FB047FC8307Q42380315-311A832C-33DC-4D0D-9AB7-0BF637E1A072Q43011930-E351C3BA-C168-447D-B752-B68037D7523D
P2860
Epidemiology of prostate cancer in the Asia-Pacific region.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiology of prostate cancer in the Asia-Pacific region.
@en
Epidemiology of prostate cancer in the Asia-Pacific region.
@nl
type
label
Epidemiology of prostate cancer in the Asia-Pacific region.
@en
Epidemiology of prostate cancer in the Asia-Pacific region.
@nl
prefLabel
Epidemiology of prostate cancer in the Asia-Pacific region.
@en
Epidemiology of prostate cancer in the Asia-Pacific region.
@nl
P2093
P2860
P356
P1476
Epidemiology of prostate cancer in the Asia-Pacific region.
@en
P2093
Danny R Youlden
Robert A Gardiner
P2860
P356
10.12954/PI.12014
P577
2013-06-30T00:00:00Z